These side effects were notably milder when compared with an inhibitor of both equally bromodomains. A detailed molecular Evaluation also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor - "Our study discovered the crucial purpose in the KLF16/MYC regulatory axis in modulating tumor https://abbv-744-clinical-trial-p13568.blogrenanda.com/38159578/the-basic-principles-of-abbv-744-in-acute-myeloid-leukemia-aml